Publications

2018

Cantu MD, Goyal A. Cytomorphology of epithelioid gastrointestinal stromal tumor. Diagn Cytopathol. 2018;46(7):636-638.
Li W, Xia S, Aronova A, Min IM, Verma A, Scognamiglio T, et al. CHL1 expression differentiates Hürthle cell carcinoma from benign Hürthle cell nodules. J Surg Oncol. 2018;118(6):1042-1049.
Santo EE, Paik J. FOXO in Neural Cells and Diseases of the Nervous System. Curr Top Dev Biol. 2018;127:105-118.
Graff RE, Ahearn TU, Pettersson A, Ebot EM, Gerke T, Penney KL, et al. Height, Obesity, and the Risk of -Defined Prostate Cancer. Cancer Epidemiol Biomarkers Prev. 2018;27(2):193-200.
Patel SS, Kuo FC, Gibson CJ, Steensma DP, Soiffer RJ, Alyea EP, et al. High -mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML. Blood. 2018;131(25):2816-2825.
Fan J, Wei Q, Koay EJ, Liu Y, Ning B, Bernard PW, et al. Chemoresistance Transmission via Exosome-Mediated EphA2 Transfer in Pancreatic Cancer. Theranostics. 2018;8(21):5986-5994.
Haffner MC, Taheri D, Luidy-Imada E, Palsgrove DN, Eich M-, Netto GJ, et al. Hypomethylation, endogenous retrovirus expression, and interferon signaling in testicular germ cell tumors. Proc Natl Acad Sci U S A. 2018;115(37):E8580-E8582.
Fontan L, Qiao Q, Hatcher JM, Casalena G, Us I, Teater M, et al. Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth. J Clin Invest. 2018;128(10):4397-4412.
Wang J, Yao Z, Jonsson P, Allen AN, Qin AC, Uddin S, et al. A Secondary Mutation in Confers Resistance to RAF Inhibition in a -Mutant Brain Tumor. Cancer Discov. 2018;8(9):1130-1141.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700